SCHEMBL14515374

SCHEMBL14515374

O=Nc1cccc(-c2nn3ccccc3c2-c2ccnc(Nc3ccccc3)n2)c1

nearest known ligand 0.56

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 12/20 0.56
▸ SLC2A1 P11166 4/20 0.56
▸ CDK2 P24941 1/20 0.56
▸ MAPK8 P45983 2/20 0.54
▸ MAPK9 P45984 2/20 0.54
▸ MAPK10 P53779 1/20 0.54
▸ AURKA O14965 1/20 0.51
▸ KDR P35968 1/20 0.51
▸ AURKB Q96GD4 1/20 0.51
▸ CDK19 Q9BWU1 1/20 0.51
▸ ABL1 P00519 1/20 0.45
▸ EGFR P00533 1/20 0.45
▸ PRKCA P17252 1/20 0.45
▸ PRKCD Q05655 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13848117 0.86 GSK3B (0.59) GSK3BSLC2A1CDK2MAPK8MAPK9
SCHEMBL3441924 0.86 GSK3B (0.58) GSK3BSLC2A1CDK2MAPK8MAPK9
SCHEMBL3441920 0.85 MAPK8 (0.60) GSK3BSLC2A1CDK2MAPK8MAPK9
SCHEMBL3542608 0.84 EGFR (0.60) GSK3BSLC2A1CDK2MAPK8MAPK9
SCHEMBL13105468 0.82 SLC2A1 (0.65) GSK3BSLC2A1CDK2MAPK8MAPK9
SCHEMBL3540905 0.81 SLC2A1 (0.65) GSK3BSLC2A1CDK2MAPK8MAPK9
SCHEMBL5225447 0.81 SLC2A1 (0.55) GSK3BSLC2A1CDK2MAPK8MAPK9
SCHEMBL13848066 0.81 TGFBR1 (0.42) GSK3BSLC2A1MAPK8MAPK9MAPK10
SCHEMBL3442634 0.81 SLC2A1 (0.82) GSK3BSLC2A1CDK2MAPK8MAPK9
SCHEMBL3441885 0.80 SLC2A1 (0.65) GSK3BSLC2A1CDK2MAPK8MAPK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1971606-B1 2-PYRIMIDINYL PYRAZOLOPYRIDINE ERBB KINASE INHIBITORS GLAXOSMITHKLINE LLC (US) 2013-04-24 — — EP disclosed
WO-2007067506-A2 2-PYRIMIDINYL PYRAZOLOPYRIDINE ERBB KINASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2007-06-14 — — WO disclosed
Send feedback